Welcome to the e-CCO Library!

P650: IBD care from the patient perspective: The patient's turn
Year: 2022
Source: ECCO'22
Authors: Creemers, R.(1);van der Horst, D.(2);Raats, I.(3);Romberg-Camps, M.(1);Scherpenzeel, M.(2);van Bodegraven, A.(1);
Created: Friday, 11 February 2022, 3:56 PM
P650: Integrin expression patterns of patients with IBD treated with vedolizumab.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kokkotis, G.(1)*;Chalakatevaki, K.(1);Papathanasiou, E.(2);Tzanoudaki, M.(3);Kane, R.(3);Liatsis, M.(3);Zampeli, E.(2);Michopoulos, S.(2);Bamias, G.(1);
Created: Friday, 14 July 2023, 11:12 AM
P650: Mechanisms of Infliximab failure: the predictive role of MMP3
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Barberio*1, R. D'Incà2, S. Facchin3, M. Dalla Gasperina1, C. Fohom1, R. Cardin1, E. Savarino2, F. Zingone1

Created: Friday, 22 February 2019, 9:41 AM
P650: The prognostic impact of radical resection margins on the Recurrence of Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

van Amesfoort J.*1, Koens L.2, Bemelman W.1, Buskens C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P651 Does ambient temperature alter faecal calprotectin levels?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Cauchi1, J. Schembri2, M. Muscat2, P. Ellul2

Created: Thursday, 30 January 2020, 10:12 AM
P651: Abstract has been withdrawn.
Year: 2022
Source: ECCO'22
Created: Friday, 11 February 2022, 3:56 PM
P651: Barriers to clinical research in children with inflammatory bowel disease: the patients' perspective
Year: 2017
Source: ECCO '17 Barcelona
Authors:

El-Matary W., Deora V.

Created: Wednesday, 20 February 2019, 10:36 AM
P651: Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, J.(1)*;Sagong, M.(1);Lee, Y.J.(1);Kim, K.O.(2);Kim, E.S.(3);Kim, E.Y.(4);Jang, B.I.(2);
Created: Friday, 14 July 2023, 11:12 AM
P651: Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn’s disease: data from administrative databases in Tuscany, Italy
Year: 2021
Source: ECCO'21 Virtual
Authors: Bertani, L.(1);Ferraro, S.(2);Bartolini, C.(3);Convertino, I.(2);Giometto, S.(2);Cappello, E.(2);Valdiserra, G.(2);Tillati, S.(2);Blandizzi, C.(2);Lucenteforte, E.(2);Gini, R.(3);Tuccori, M.(2,4);Costa, F.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P651: Disease severity and intensity of therapy predicts serious adverse events in paediatric ulcerative colitis: the DEVELOP experience
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Winter*1, J. Izanec2, C. Busse2, Y. Wang3, J. Hyams4

Created: Friday, 22 February 2019, 9:41 AM
P651: Reliability of blood tests, neutrophil lymphocyte ratio (NLR) and Glasgow prognostic index (GPI) to evaluate the severity of the Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.O. Gur1*, S. Karaisli1, O.N. Dilek1, T. Acar1, S. Haciyanli1, B. Unsal2, M. Haciyanli1

Created: Thursday, 21 February 2019, 9:14 AM
P652 Underweight patients with Crohn’s disease and without vitamin D supplementation are at high risk of vitamin D deficiency
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Vranesic Bender1, V. Domislović2, M. Brinar2,3, D. Ljubas Kelečić1, I. Karas1, M. Novosel3, M. Matašin3, Ž. Krznarić1,2,3

Created: Thursday, 30 January 2020, 10:12 AM
P652: Compare risk factors associated with infectious complication in Crohn’s disease with and without preoperative infliximab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

X. Ge*1, Q. Cao2, W. Zhou1

Created: Friday, 22 February 2019, 9:41 AM
P652: Nutritional adequacy of popular defined diets for inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Nazarenkov1, L. Beeken2, K. Seeger2, A. Ananthakrishnan3, H. Khalili3, J. Lewis4, G. Konijeti2,5*

Created: Thursday, 21 February 2019, 9:14 AM
P652: The burden of mental illness, including deliberate self-harm, before and after a diagnosis of IBD, a UK population study.
Year: 2022
Source: ECCO'22
Authors: Umar, D.N.(1);Harvey, P.(2);King, D.(3);Chandan, J.(4);Adderley, N.(4);Nirantharakumar, K.(4);Trudgill, N.(5);
Created: Friday, 11 February 2022, 3:56 PM
P652: Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mínguez, A.(1)*;Bastida, G.(1);Terol, I.(1);Argumánez, V.(1);Iborra, M.(1);Aguas, M.(1);Moret, I.(2);Cerrillo, E.(1);Garrido, A.(1);Tortosa, L.(1);Nos, P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P652: Treatment patterns in patients receiving outpatient care for inflammatory bowel disease in Russian Federation
Year: 2021
Source: ECCO'21 Virtual
Authors: Uspenskiy, Y.(1);Galagudza, M.(2);Ivanov, S.(3);Fominikh, Y.(3);Dreval, R.(4);Mayorova, O.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P652: Unmet needs of physicians managing inflammatory bowel disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Saibeni S.*1, Bezzio C.1, Armuzzi A.2, Bossa F.3, Calabrese E.4, Caprioli F.5, Daperno M.6, Mocciaro F.7, Orlando A.8, Papi C.9, Rispo A.10, Rizzello F.11 IG-IBD

Created: Wednesday, 20 February 2019, 10:36 AM
P653 Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Updated results of the OCTAVE Open study for tofacitinib 8-week induction non-responders
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D.T. Rubin1, M.C. Dubinsky2, S. Danese3, R. Saad-Hossne4, D. Ponce de Leon5, E. Maller6, N. Lawendy6, K. Kwok7, C. Su6

Created: Thursday, 30 January 2020, 10:12 AM
P653: Impact of ileostomy on recurrence rate after ileo-colic resection for Crohn’s disease: A critical appraisal from a referral centre
Year: 2018
Source: ECCO '18 Vienna
Authors:

B. Sensi1, S. D'Ugo1,2*, G. Bagaglini1, A. Di Giorgio1, L. Fazzolari1, G. Sica1

Created: Thursday, 21 February 2019, 9:14 AM